ACJW MEDICAL LIMITED

🌳Matureactive
07472320 · ltd · incorporated 2010-12-16
Investment thesis
Well-run mature business — low negotiation leverage; premium likely.
Why interesting: Textbook target; clean filings, stable trading.
Why risky: No pressure on seller; any deal likely at full price.
Opportunity decay
hardening · 12-months
Already tight — no obvious softening catalysts on the horizon.
  • · Thesis: well-run, low negotiation leverage
🔒Estimated value
Upgrade to see
Turnover
year to Mar 2025
Net worth
£1.21M
book net assets
Opportunity
80/100
Exceptional
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Specialist medical practice activities
Sector: Human health & social work
Investor take
Pursue
Asset-holding vehicle with a 64-year-old founder — textbook succession opportunity.

Opportunity 80/100 (exceptional), bankability 75/100. Strong seller-intent signal (70/100, director aged 64). Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (73/100).

Data confidence

Overall: medium (78/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
2 officers (2 active, 2 linked, 2 with DOB)
90
Ownership & PSC
2 active PSC(s) of 2 total, 2 with control declared
90
Director network
Network not yet resolved
30
Filing history
41 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
80/100Exceptional
PassWatchWorth a lookStrongExceptional 

Strong composite across quality, acquirability, and risk. High-priority target — progress to serious diligence.

Business quality
70
Active, clean filings, stable charge profile.
Acquirability
80
Strong succession / seller-readiness signals.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · accounting standard not declared
Positive net assets
Net assets £1,212,678
Cash YoY
+36%
Year on year

Key financials

2 years extracted from filed iXBRL accounts
Cash
£636k
↑ 36% YoY
Net Worth
£1.2m
↑ 13% YoY
Current Assets
£1.3m
↑ 16% YoY
Current Liabilities
£0£254k£507k£761k£1.0m£1.3mMar 2024Mar 2025

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · accounting standard unknown
Metric2025-03-312024-03-31
Total assets£1.21M£1.08M
Current assets£1.27M£1.09M
Cash£635.9k£466.6k
Debtors£106.9k£106.5k
Net assets£1.21M£1.08M

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
0
filings
Last 90 days
0
filings
Last 180 days
4
filings
  • 2 persons-with-significant-control
  • 1 confirmation-statement
  • 1 accounts
Counts from Companies House filing history.
Corporate timeline (19 events)Click to expand
  1. 2026-01-02
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  2. 2026-01-02
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  3. 2025-12-24
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  4. 2024-12-24
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  5. 2023-12-31
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  6. 2023-03-28
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  7. 2021-12-29
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  8. 2020-12-31
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  9. 2019-12-30
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  10. 2018-09-07
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  11. 2018-05-11
    📄
    change-person-director-company-with-change-date
    officers · CH01
  12. 2018-05-11
    📄
    change-person-director-company-with-change-date
    officers · CH01
  13. 2018-05-11
    📄
    change-person-director-company-with-change-date
    officers · CH01
  14. 2018-05-09
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  15. 2017-12-19
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  16. 2017-07-21
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  17. 2010-12-16
    🏢
    Company incorporated
    As ACJW MEDICAL LIMITED
  18. 2010-12-16
    WINDSOR, Alastair Colin James appointed
    director
  19. 2010-12-16
    WINDSOR, Elizabeth Mary appointed
    director

Owner dependency

89/100
Critical — business is the founder

The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.

FACTORS
  • +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
  • +Long-tenure founder: Senior director has been in place 15 years — deep operational knowledge concentrated in one person.
  • +Senior director age: Director aged approximately 64 — approaching natural succession window.
  • +Family involvement: Multiple officers share a surname — likely family business, which concentrates governance.
  • +No director turnover: Company is 15 years old with no director changes — suggests a very tight-knit founder team never broadened.

Succession & seller-readiness

79/100
Likely off-market candidate

Strong acquirability signals converging. Worth approaching directly — this is how off-market deals start.

SIGNALS
  • primaryFounder aged 63+: Senior director is approximately 64. Approaching typical UK retirement age — succession thinking likely.
  • secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
  • secondary12+ year tenure: Director in role 15 years.
  • secondaryStable-but-static management: Company is 15 years old and no new directors in the last 3 years — succession not yet being planned internally.
  • supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

2 active beneficial owners
NameSharesVoting rightsNature of controlNotified
Elizabeth Mary Windsor
Individual · Irish · DOB 05/1969 · age 57
2550%
25–50%25-50% shares · 25-50% voting06/04/2016
Alastair Colin James Windsor
Individual · British · DOB 03/1962 · age 64
2550%
25–50%25-50% shares · 25-50% voting06/04/2016

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

Similar companies

Active · Healthcare & medical · TN postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
360 EVENTS & RETREATS LIMITED
16903225 · est 2025 · no financials extracted
360VSE LTD
13822231 · est 2021 · no financials extracted
4y
50 CHALLENGES LIMITED
10944550 · est 2017 · no financials extracted
8y
A JANDZIOL LTD
14721168 · est 2023 · no financials extracted
3y
A JULLINGS LTD
16566781 · est 2025 · no financials extracted
A. G. SMILES LTD
11433391 · est 2018 · no financials extracted
7y
AAMIR AND IMAN LIMITED
14408343 · est 2022 · no financials extracted
3y
ABIDE BY MAJESTIC CEDAR LTD
16779499 · est 2025 · no financials extracted
ABSOLUTE EYES BYP LIMITED
10790630 · est 2017 · no financials extracted
8y
ACCURO WELLBEING LIMITED
12805592 · est 2020 · no financials extracted
5y
ACE INDIA LIMITED
06093925 · est 2007 · no financials extracted
19y
AD INTEGRUM VASCULAR & WOUND CARE LTD
12079603 · est 2019 · no financials extracted
6y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2010-12-16
Jurisdictionengland-wales
Primary SIC86220 — Specialist medical practice activities

Registered office

2 St. Marys Road
Tonbridge
Kent
TN9 2LB
England

Filing status

Accounts
Next due: 2026-12-31
Last made up to: 2025-03-31
Confirmation statement
Next due: 2026-12-30
Last: 2025-12-16

Officers (2 active · 0 resigned)

WINDSOR, Alastair Colin James
director · ~64y · appointed 2010-12-16
View their other companies + combined net worth →
Active
WINDSOR, Elizabeth Mary
director · ~57y · appointed 2010-12-16
View their other companies + combined net worth →
Active

Click a director name to see their full track record across all companies.

Recent filings (41 total)

confirmation-statement-with-updates
confirmation-statement · CS01
2026-01-05
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2026-01-02
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2026-01-02
accounts-with-accounts-type-total-exemption-full
accounts · AA
2025-12-24
accounts-with-accounts-type-total-exemption-full
accounts · AA
2024-12-24
confirmation-statement-with-updates
confirmation-statement · CS01
2024-12-18
confirmation-statement-with-no-updates
confirmation-statement · CS01
2023-12-31
accounts-with-accounts-type-total-exemption-full
accounts · AA
2023-12-31
accounts-with-accounts-type-total-exemption-full
accounts · AA
2023-03-28
confirmation-statement-with-no-updates
confirmation-statement · CS01
2022-12-30
confirmation-statement-with-updates
confirmation-statement · CS01
2021-12-29
accounts-with-accounts-type-total-exemption-full
accounts · AA
2021-12-29
confirmation-statement-with-updates
confirmation-statement · CS01
2021-01-04
accounts-with-accounts-type-total-exemption-full
accounts · AA
2020-12-31
accounts-with-accounts-type-total-exemption-full
accounts · AA
2019-12-30